ENST00000590627.5:n.232T>C
Variant names: 
Variant summary
Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBA1
The ENST00000590627.5(GCDH):n.232T>C variant causes a non coding transcript exon change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.037 in 1,613,942 control chromosomes in the GnomAD database, including 1,326 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).
Frequency
 Genomes: 𝑓 0.048   (  241   hom.,  cov: 33) 
 Exomes 𝑓:  0.036   (  1085   hom.  ) 
Consequence
 GCDH
ENST00000590627.5 non_coding_transcript_exon
ENST00000590627.5 non_coding_transcript_exon
Scores
 3
Clinical Significance
Conservation
 PhyloP100:  -0.0910  
Publications
5 publications found 
Genes affected
 GCDH  (HGNC:4189):  (glutaryl-CoA dehydrogenase) The protein encoded by this gene belongs to the acyl-CoA dehydrogenase family. It catalyzes the oxidative decarboxylation of glutaryl-CoA to crotonyl-CoA and CO(2) in the degradative pathway of L-lysine, L-hydroxylysine, and L-tryptophan metabolism. It uses electron transfer flavoprotein as its electron acceptor. The enzyme exists in the mitochondrial matrix as a homotetramer of 45-kD subunits. Mutations in this gene result in the metabolic disorder glutaric aciduria type 1, which is also known as glutaric acidemia type I. Alternative splicing of this gene results in multiple transcript variants. A related pseudogene has been identified on chromosome 12. [provided by RefSeq, Mar 2013] 
GCDH Gene-Disease associations (from GenCC):
- glutaryl-CoA dehydrogenase deficiencyInheritance: AR Classification: DEFINITIVE, STRONG, MODERATE, SUPPORTIVE Submitted by: ClinGen, Labcorp Genetics (formerly Invitae), Genomics England PanelApp, Orphanet, G2P, Myriad Women’s Health
Genome browser will be placed here
ACMG classification
Classification was made for transcript
Our verdict: Benign. The variant received -20 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.88). 
BP6
Variant 19-12891570-T-C is Benign according to our data. Variant chr19-12891570-T-C is described in ClinVar as Benign. ClinVar VariationId is 255394.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. 
BA1
GnomAd4 highest subpopulation (AFR) allele frequency at 95% confidence interval = 0.0859  is higher than 0.05. 
Transcripts
RefSeq
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt | 
|---|---|---|---|---|---|---|---|---|
| GCDH | NM_000159.4 | c.127+48T>C | intron_variant | Intron 3 of 11 | ENST00000222214.10 | NP_000150.1 | ||
| GCDH | NR_102317.1 | n.283T>C | non_coding_transcript_exon_variant | Exon 3 of 11 | ||||
| GCDH | NM_013976.5 | c.127+48T>C | intron_variant | Intron 3 of 11 | NP_039663.1 | |||
| GCDH | NR_102316.1 | n.235+48T>C | intron_variant | Intron 3 of 11 | 
Ensembl
Frequencies
GnomAD3 genomes  0.0480  AC: 7303AN: 152178Hom.:  243  Cov.: 33 show subpopulations 
GnomAD3 genomes 
 AF: 
AC: 
7303
AN: 
152178
Hom.: 
Cov.: 
33
Gnomad AFR 
 AF: 
Gnomad AMI 
 AF: 
Gnomad AMR 
 AF: 
Gnomad ASJ 
 AF: 
Gnomad EAS 
 AF: 
Gnomad SAS 
 AF: 
Gnomad FIN 
 AF: 
Gnomad MID 
 AF: 
Gnomad NFE 
 AF: 
Gnomad OTH 
 AF: 
GnomAD2 exomes  AF:  0.0338  AC: 8497AN: 251134 AF XY:  0.0328   show subpopulations 
GnomAD2 exomes 
 AF: 
AC: 
8497
AN: 
251134
 AF XY: 
Gnomad AFR exome 
 AF: 
Gnomad AMR exome 
 AF: 
Gnomad ASJ exome 
 AF: 
Gnomad EAS exome 
 AF: 
Gnomad FIN exome 
 AF: 
Gnomad NFE exome 
 AF: 
Gnomad OTH exome 
 AF: 
GnomAD4 exome  AF:  0.0359  AC: 52451AN: 1461646Hom.:  1085  Cov.: 35 AF XY:  0.0357  AC XY: 25925AN XY: 727104 show subpopulations 
GnomAD4 exome 
 AF: 
AC: 
52451
AN: 
1461646
Hom.: 
Cov.: 
35
 AF XY: 
AC XY: 
25925
AN XY: 
727104
show subpopulations 
African (AFR) 
 AF: 
AC: 
3100
AN: 
33474
American (AMR) 
 AF: 
AC: 
1179
AN: 
44722
Ashkenazi Jewish (ASJ) 
 AF: 
AC: 
674
AN: 
26134
East Asian (EAS) 
 AF: 
AC: 
483
AN: 
39698
South Asian (SAS) 
 AF: 
AC: 
2785
AN: 
86242
European-Finnish (FIN) 
 AF: 
AC: 
655
AN: 
53392
Middle Eastern (MID) 
 AF: 
AC: 
239
AN: 
5618
European-Non Finnish (NFE) 
 AF: 
AC: 
41017
AN: 
1111980
Other (OTH) 
 AF: 
AC: 
2319
AN: 
60386
 Allele Balance Distribution 
 Red line indicates average allele balance 
 Average allele balance: 0.490 
Heterozygous variant carriers
 0 
 3173 
 6345 
 9518 
 12690 
 15863 
 0.00 
 0.20 
 0.40 
 0.60 
 0.80 
 0.95 
Allele balance
Age Distribution
Exome Het
Exome Hom
Variant carriers
 0 
 1540 
 3080 
 4620 
 6160 
 7700 
 <30 
 30-35 
 35-40 
 40-45 
 45-50 
 50-55 
 55-60 
 60-65 
 65-70 
 70-75 
 75-80 
 >80 
Age
GnomAD4 genome  0.0480  AC: 7307AN: 152296Hom.:  241  Cov.: 33 AF XY:  0.0452  AC XY: 3370AN XY: 74480 show subpopulations 
GnomAD4 genome 
 AF: 
AC: 
7307
AN: 
152296
Hom.: 
Cov.: 
33
 AF XY: 
AC XY: 
3370
AN XY: 
74480
show subpopulations 
African (AFR) 
 AF: 
AC: 
3668
AN: 
41562
American (AMR) 
 AF: 
AC: 
582
AN: 
15304
Ashkenazi Jewish (ASJ) 
 AF: 
AC: 
97
AN: 
3472
East Asian (EAS) 
 AF: 
AC: 
40
AN: 
5180
South Asian (SAS) 
 AF: 
AC: 
138
AN: 
4830
European-Finnish (FIN) 
 AF: 
AC: 
96
AN: 
10630
Middle Eastern (MID) 
 AF: 
AC: 
9
AN: 
294
European-Non Finnish (NFE) 
 AF: 
AC: 
2589
AN: 
68002
Other (OTH) 
 AF: 
AC: 
87
AN: 
2110
 Allele Balance Distribution 
 Red line indicates average allele balance 
 Average allele balance: 0.502 
Heterozygous variant carriers
 0 
 363 
 726 
 1088 
 1451 
 1814 
 0.00 
 0.20 
 0.40 
 0.60 
 0.80 
 0.95 
Allele balance
Age Distribution
Genome Het
Genome Hom
Variant carriers
 0 
 76 
 152 
 228 
 304 
 380 
 <30 
 30-35 
 35-40 
 40-45 
 45-50 
 50-55 
 55-60 
 60-65 
 65-70 
 70-75 
 75-80 
 >80 
Age
Alfa 
 AF: 
Hom.: 
Bravo 
 AF: 
Asia WGS 
 AF: 
AC: 
89
AN: 
3478
ClinVar
Significance: Benign 
Submissions summary: Benign:4 
Revision: criteria provided, multiple submitters, no conflicts
LINK: link 
Submissions by phenotype
not provided    Benign:2 
-
Breakthrough Genomics, Breakthrough Genomics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:not provided
- -
Mar 03, 2015
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing
- -
not specified    Benign:1 
-
PreventionGenetics, part of Exact Sciences
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing
- -
Glutaric aciduria, type 1    Benign:1 
Jun 10, 2021
Genome-Nilou Lab
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing
- -
Computational scores
Source: 
Name
Calibrated prediction
Score
Prediction
 AlphaMissense 
 Benign 
 BayesDel_noAF 
 Benign 
 DANN 
 Benign 
 PhyloP100 
Splicing
Name
Calibrated prediction
Score
Prediction
 SpliceAI score (max) 
Details are displayed if max score is > 0.2
 Find out detailed SpliceAI scores and Pangolin per-transcript scores at 
Publications
 You must be logged in to view publications. This limit was set because tens of millions (!) of queries from AI bots are generated daily.